Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$96.41 - $126.61 $19,282 - $25,322
200 Added 400.0%
250 $25,000
Q4 2022

Feb 01, 2023

SELL
$118.38 - $210.04 $23,676 - $42,008
-200 Reduced 80.0%
50 $9,000
Q3 2021

Oct 21, 2021

BUY
$221.9 - $484.47 $44,380 - $96,894
200 Added 400.0%
250 $96,000
Q4 2020

Feb 08, 2021

BUY
$65.74 - $169.86 $3,286 - $8,493
50 New
50 $5,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Arrow Financial Corp Portfolio

Follow Arrow Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.